Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its ...

We recently published a list of Jim Cramer’s February Portfolio: Top 10 Stocks. In this article, we are going to take a look ...

Before the A380, Lockheed Martin had an idea for a double checker super transport plane. An insane aircraft designed in 1996 ...

German Chancellor Olaf Scholz said on Monday (February 3) that the European Union is strong enough to react to any tariffs ...

A new tool has just started its roll out in Tennessee to make places in our state more accessible to everyone.

Hundreds of people in Scotland's Shetland Islands marched with burning torches alongside a replica Viking ship on Tuesday ...

The text of the Saga of Egil Skallagrimsson reads more like a Monty Python screenplay than a testament to the deeds of a real ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Go ahead and Subscribe here. Passengers aboard Viking Ocean’s Viking Vela are still docked in Ålesund after a 3-day unscheduled visit to the Norwegian city located on the Norwegian Sea.

The glasses have been tested by over 300 blind individuals from nearly 30 countries, with overwhelmingly positive feedback. Gutt recalls witnessing users walk independently without white canes for ...

Viking Therapeutics has announced the start of a Phase II clinical trial for VK2735, an oral tablet aimed at treating metabolic disorders, such as obesity. The VENTURE-Oral Dosing Trial is a ...